Changes to Prescriber ‘FS’ Endorsement

The prescriber ‘FS’ endorsement was originally introduced to enable free supply of items prescribed for the treatment of sexually transmitted infections (STIs). From 1st December 2025, use of the ‘FS’ endorsement has been extended to items used in the management of tuberculosis (TB) latent TB infections, the effects of TB; and the adverse effects from TB treatment. 

For more information...